2DG, a glucose analogue that inhibits glycolysis but can be redirected towards the PPP to generate NADPH,64 explains its ability to protect SLC7A11‐high cancer cells from cell death under conditions of glucose deprivation. This evidence concerns the gene SLC7A11 and cancer.